Skip to main content

Peer Review reports

From: Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis

Original Submission
9 Mar 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
11 Apr 2022 Reviewed Reviewer Report
22 Apr 2022 Reviewed Reviewer Report
11 May 2022 Author responded Author comments - Ichidai Tanaka
Resubmission - Version 3
11 May 2022 Submitted Manuscript version 3
13 May 2022 Author responded Author comments - Ichidai Tanaka
Resubmission - Version 4
13 May 2022 Submitted Manuscript version 4
18 May 2022 Reviewed Reviewer Report
5 Jun 2022 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
6 Jun 2022 Editorially accepted
14 Jun 2022 Article published 10.1186/s12885-022-09741-8

You can find further information about peer review here.

Back to article page